AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

This article explores how decentralized clinical trials transform biotech drug development, enhancing patient access and ...

Slope is the only end-to-end, vendor-agnostic platform for managing biospecimens and clinical inventory across the entire clinical research ecosystem. Trusted by 2,200+ sites in 23+ countries, Slope ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Treatment through a clinical trial may be an option for some people with leukemia. Several factors may influence your decision to join a clinical trial, so it’s important to gather as much information ...

When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...

Clinical trials are conducted in several phases to determine whether new treatments are safe and effective. The results from Phases 1, 2 and 3 inform the U.S. Food and Drug Administration (FDA) on ...

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

2. Trial visits are kept to a minimum with potential utilization of telemedicine or stipends increase attendance 3. Trial mimics typical clinical workflow with minimization of visits, and laboratory ...

Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...

Classification of Multiplicity Problems A wide variety of multiplicity problems may be encountered in clinical trials. When multiplicity is caused by a single factor (e.g., analysis of multiple end ...